News about Biotechnology

Eisai and Nuvation Bio Secure EMA Validation for Taletrectinib in Lung Cancer

EU regulator begins review of next-generation targeted therapy for advanced ROS1-positive non-small cell lung cancer.

Biotechnology | 30/03/2026 | By News Bureau |  163

Medtronic Secures FDA Nod for Stealth AXiS, Advancing Integrated Surgical Technology Manufacturing

Medtronic, a global leader in healthcare technology, has received clearance from the US Food and Drug Administration (FDA) for its Stealth AXiS surgical system for use in cranial and ear, nose, and throat (ENT) procedures.

Biotechnology | 30/03/2026 | By Darshana

UK Regulator Pushes Shift Toward Reduced Animal Testing, Issues Roadmap for Alternative Methods

The UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency, has outlined new guidance aimed at reducing reliance on animal testing and accelerating the adoption of alternative scientific methods in drug development.

Biotechnology | 26/03/2026 | By Darshana |  104

Alteogen and Biogen Sign Deal for Hybrozyme-Based Subcutaneous Biologics

Alteogen signs a licensing deal with Biogen to develop and commercialise Hybrozyme-based subcutaneous biologics, granting rights for two products using the ALT-B4 platform.

Biotechnology | 26/03/2026 | By News Bureau |  201

Biocytogen Pharmaceuticals Beijing Partners Moonlight Bio to Advance Next-Generation Cancer Cell Therapies

The strategic collaboration between Biocytogen Pharmaceuticals Beijing and Moonlight Bio aims to combine antibody discovery and cell therapy expertise to develop innovative treatments for hard-to-treat cancers.

Biotechnology | 25/03/2026 | By News Bureau |  134

Co-Diagnostics Expands CoSara's South Asia Footprint, Targets USD 13 Billion Diagnostics Market

Co-Diagnostics, Inc. has announced a strategic expansion of its South Asia operations through its joint venture CoSara Diagnostics Pvt. Ltd., formed in partnership with Ambalal Sarabhai Enterprises Limited.

Biotechnology | 23/03/2026 | By Darshana |  131

From Generics to Biologics: Semaglutide Reshapes Pharma Manufacturing in India

The recent developments around semaglutide in India—triggered by patent expiry and rapid domestic entry—are poised to significantly reshape the country’s pharmaceutical manufacturing landscape.

Biotechnology | 23/03/2026 | By Darshana |  182

Belief Pharmaceuticals Group Has Announced that its Gene Therapy BM-H901 Injection Has Received Approval from the Macau

Belief Pharmaceuticals Group has announced that its gene therapy BM-H901 injection (generic name: Popedacoq injection) has received approval from the Macau Drug Administration for treating adult patients with moderate to severe haemophilia B (congenital factor IX deficiency).

Biotechnology | 22/03/2026 | By Darshana |  109

GI Innovation, Johnson & Johnson Partner for Phase Ib Trial in Advanced Prostate Cancer

GI Innovation enters clinical supply agreement with Johnson & Johnson to evaluate GI-102 and pasritamig combination therapy in metastatic castration-resistant prostate cancer patients.

Biotechnology | 21/03/2026 | By News Bureau |  154

Zydus Lifesciences Launches Aerolife Mini, India's First Portable Foldable Spacer

Zydus introduces Aerolife Mini, a compact pMDI enhancer designed to improve inhaler drug delivery and patient compliance in respiratory care through a convenient, foldable design.

Biotechnology | 20/03/2026 | By News Bureau |  136